Combination approaches in hepatocellular carcinoma: How systemic treatment can benefit candidates to locoregional modalities
The management of hepatocellular carcinoma (HCC) is challenging because mostRead more
Non-alcoholic fatty liver disease-related hepatocellular carcinoma: Is there a role for immunotherapy?
Review . 2022 Jul 28;28(28):3595-3607. doi: 10.3748/wjg.v28.i28.3595. Affiliations Expand AffiliationsRead more
Knockdown of the long non-coding RNA CACNA1G-AS1 enhances cytotoxicity and apoptosis of human diffuse large...
doi: 10.3892/etm.2022.11564. eCollection 2022 Oct. Affiliations Expand Affiliations 1 DepartmentRead more
Occurrence of hyperprogressive disease following administration of immune checkpoint inhibitors in lung squamous cell carcinoma:...
Case Reports doi: 10.3892/etm.2022.11554. eCollection 2022 Oct. Affiliations Expand AffiliationsRead more
doi: 10.3892/etm.2022.11575. eCollection 2022 Oct. Affiliations Expand Affiliations 1 DepartmentRead more
doi: 10.3892/etm.2022.11578. eCollection 2022 Oct. Affiliations Expand Affiliations 1 DepartmentRead more
doi: 10.1002/jbmr.4714. Online ahead of print. Janice L Pasieka 1Read more
Development and validation of a gene model predicting lymph node metastasis and prognosis of oral...
Backgrounds: Lymph node (LN) metastasis can independently predict oral squamousRead more